Company news

Immunome, Inc. news in 2025

Immunome, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Immunome Announces Pricing of Public Offering of Common Stock

December 15, 2025

Immunome Announces Proposed Public Offering of Common Stock

December 14, 2025

Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

December 14, 2025

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

December 13, 2025

Immunome to Present at Upcoming Investor Conferences

November 24, 2025

Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update

November 5, 2025

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

October 30, 2025

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

October 22, 2025

Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025

Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update

August 6, 2025

Immunome to Present at Upcoming Investor Conferences

May 21, 2025

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update

May 11, 2025

Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference

April 3, 2025

Immunome Reports Full Year 2024 Financial Results and Provides Business Update

March 18, 2025

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC

March 9, 2025

Immunome to Present at Upcoming March Conferences

February 24, 2025

Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer

February 10, 2025

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

January 30, 2025

Immunome Announces Pricing of Upsized Public Offering of Common Stock

January 28, 2025

Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

January 12, 2025

Decks in 2025